Streetbeat News

Regulatory

BTCUSD

Senator Bill Hagerty (R-TN) emphasized the Republican Party's evolving stance on cryptocurrencies, highlighting former President Donald Trump's commitment to making the U.S. a 'crypto hub.' Hagerty criticized the Biden administration for regulatory actions against the industry and reiterated the need for the U.S. to embrace digital currencies to prevent China from dominating the field.

Portfolio Pulse from Aniket Verma

July 31, 2024 | 5:41 am

BBJP

DXJ

EWJ

The Bank of Japan has decided to raise its interest rate to 0.25%, up from the previous 0.10% and higher than the estimated 0.10%. This decision could impact various Japan-focused ETFs listed in the US.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 4:19 am

ETHUSD

MATICUSD

A trader on Polymarket lost $72,000 after betting on Trump's victory in the upcoming presidential elections. Trump's odds fell 12% after Kamala Harris replaced Biden as the Democratic nominee. Polymarket, built on Ethereum's Layer-2 chain Polygon, has become a leading prediction market for U.S. elections.

Portfolio Pulse from Aniket Verma

July 31, 2024 | 1:39 am

FHN

First Horizon's 2024 capital stress test results show a strong resilience with a CET1 ratio of 9.5%, which is 500 basis points above the regulatory minimum. This reflects the company's diversified loan portfolio and strong risk culture.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:59 pm

COP

CVX

EOG

IYE

MRO

USO

VDE

XLE

XOM

Tensions in Venezuela rise as opposition disputes election results, impacting oil ETFs. Major oil companies and ETFs saw gains, except for the United States Oil Fund (USO), which traded lower.

Portfolio Pulse from Anthony Noto

July 30, 2024 | 8:58 pm

VST

Vistra shares are trading higher after the company announced that the Nuclear Regulatory Commission has approved its request to extend the operation of Comanche Peak Nuclear Power Plant through 2053.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:49 pm

VST

Vistra has received approval from the NRC to operate the Comanche Peak Nuclear Plant through 2053. The 2,400-megawatt plant will continue to provide reliable, zero-carbon electricity.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:49 pm

FGEN

Trading halt status for FibroGen Inc. (FGEN) was updated at 4:30 PM ET. The article provides information on the news and resumption times.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:30 pm

TECX

Tectonic Therapeutic, Inc. (NASDAQ: TECX) has received FDA clearance for its Investigational New Drug (IND) application for TX45, an Fc-relaxin fusion protein aimed at treating Group 2 Pulmonary Hypertension due to Heart Failure with Preserved Ejection Fraction (PH-HFpEF). The company plans to initiate a global Phase 2 clinical trial in Q3 2024, with topline results expected in 2026. Phase 1a results in healthy volunteers are expected this September, and Phase 1b results in mid-2025.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:22 pm

MGNX

MacroGenics provided an update on its Vobramitamab Duocarmazine (vobra duo) program, including the TAMARACK study. The study reached its primary endpoint, leading to the discontinuation of additional dosing for remaining participants. The company plans to present data at the ESMO Congress 2024 and expects to have mature efficacy findings later in the year.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:20 pm